DR
Deval Rajnikant Shah
About Deval Rajnikant Shah
Data last updated:
Deval Rajnikant Shah is a Whole-Time Director at Senores Pharmaceuticals Limited (since 2020) and Non- Individual Subscriber at Senores Foundation (since 2025). The companies operate in Pharma and Engineering. The largest current company by reported revenue is Senores Pharmaceuticals Limited at ₹418 Cr (FY 2025). Earlier, Deval Rajnikant Shah was a Cfo at Sai Consulting Engineers Private Limited (2014–2019) and Director at Ratnagene Lifescience Private Limited (from 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 01 Jan 2020 | 2017 | ₹418 Cr (FY 2025) | Active | |
| Non- Individual Subscriber | 25 Nov 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 06 Nov 2014 | 1983 | ₹104 Cr (FY 2025) | Active | |
| Director | 05 Feb 2024 | 2021 | ₹1.98 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Deval Rajnikant Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arpit Deepakkumar Shah | 07214641 | Senores Pharmaceuticals Limited | Director |
| Ashokkumar Vijaysinh Barot | 01192300 | Senores Pharmaceuticals Limited | Director |
| Chetan Bipinchandra Shah | 10381971 | Senores Pharmaceuticals Limited | Whole-Time Director |
| Hemanshu Nitinchandra Pandya | 10383995 | Senores Pharmaceuticals Limited | Director |
| Jitendra Babulal Sanghvi | 00271995 | Senores Pharmaceuticals Limited | Director |
| Kalpit Rajesh Gandhi | 02843308 | Senores Pharmaceuticals Limited | Director |
| Manjula Devi Shroff | 00297159 | Senores Pharmaceuticals Limited , Senores Foundation | Director |
| Naresh Bansilal Shah | 10384306 | Senores Pharmaceuticals Limited | Director |
| Sanjay Shaileshbhai Majmudar | 00091305 | Senores Pharmaceuticals Limited | Director |
| Swapnil Jatinbhai Shah | 05259821 | Senores Pharmaceuticals Limited | Managing Director |
| Udayan Dileep Choksi | 02222020 | Senores Pharmaceuticals Limited | Director |
| Anar Swapnil Shah | 06895297 | Senores Foundation | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deval Rajnikant Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deval Rajnikant Shah
Deval Rajnikant Shah currently holds 2 directorships: Senores Pharmaceuticals Limited (Whole-Time Director, since 01 Jan 2020, revenue βΉ418 Cr (FY 2025)); Senores Foundation (Non- Individual Subscriber, since 25 Nov 2025).
Deval Rajnikant Shah was first appointed on 06 Nov 2014 as Cfo at Sai Consulting Engineers Private Limited. The most recent appointment on record is 25 Nov 2025 at Senores Foundation.
Deval Rajnikant Shah held 2 earlier board appointments: Sai Consulting Engineers Private Limited (Cfo, 06 Nov 2014 to 12 Jun 2019); Ratnagene Lifescience Private Limited (Director, from 05 Feb 2024).
The current boards of Deval Rajnikant Shah's companies include Arpit Deepakkumar Shah (Senores Pharmaceuticals Limited), Ashokkumar Vijaysinh Barot (Senores Pharmaceuticals Limited), Chetan Bipinchandra Shah (Senores Pharmaceuticals Limited), Hemanshu Nitinchandra Pandya (Senores Pharmaceuticals Limited), Jitendra Babulal Sanghvi (Senores Pharmaceuticals Limited), Kalpit Rajesh Gandhi (Senores Pharmaceuticals Limited), among others.